Inactive Instrument
Quotes GENFIT Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Basic data
Market Cap (EUR)
674,864,896
Market Cap (USD)
769,427,541
Net sales (EUR)
71,115,000
Net sales (USD)
81,079,694
Free-Float
86.88 %
Free-Float capitalization (EUR)
586,501,038
Free-Float capitalization (USD)
668,682,064
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 769M | |
| -0.24% | +1.85% | +3.13% | +9.14% | 49.74B | |
| -0.36% | +1.21% | +420.77% | +619.10% | 40.49B | |
| -2.13% | +0.29% | +23.91% | -6.01% | 34.75B | |
| -2.29% | +3.83% | +23.48% | +59.26% | 34.35B | |
| -0.79% | +1.32% | +5.78% | +36.42% | 26.98B | |
| +3.82% | +3.51% | - | - | 16.58B | |
| -2.62% | -2.13% | +64.96% | +125.87% | 15.6B | |
| -2.17% | +6.65% | +104.31% | +102.15% | 14.27B | |
| -2.70% | -2.04% | +12.37% | +18.19% | 13.76B | |
| Average | -1.05% | +1.48% | +82.34% | +120.52% | 24.73B | |
| Weighted average by Cap. | -1.00% | +1.53% | +94.19% | +139.18% |
Historical Quotes: GENFIT
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- GNFT Stock
- Stock
- Quotes GENFIT
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
